[THE INVESTOR] Ahngook Pharmaceutical announced on Oct. 12 that it has signed an agreement with multinational pharmaceutical company Menarini for sales rights of its cough syrup Synatura in seven Central American countries.

The Italy-based company will have sales and marketing rights of the cough and mucus reducer in Guatemala, Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Belize. The contract amount remains undisclosed. 



Synatura Syrup was introduced in 2011 by the South Korean firm.

By Hwang You-mee (glamazon@heraldcorp.com)